Correction: FOXC1 promotes melanoma by activating MST1R/PI3K/AKT pathway and is associated with poor prognosis in melanoma.

Publication Title

Oncotarget

Authors

Jinhua Wang, Department of Molecular Oncology, John Wayne Cancer Institute (JWCI) at Providence Saint John's Health Center, Santa Monica 90404, CA, USA.
Li Li
Shiwei Liu
Ying Zhao
Lin Wang
Guanhua Du

Document Type

Article

Publication Date

6-13-2024

Keywords

california; sjci; santa monica

Clinical Institute

Cancer

Specialty

Dermatology

Specialty

Endocrinology

Specialty

Oncology

DOI

10.18632/oncotarget.28590

Recommended Citation

Wang, Jinhua; Li, Li; Liu, Shiwei; Zhao, Ying; Wang, Lin; and Du, Guanhua, "Correction: FOXC1 promotes melanoma by activating MST1R/PI3K/AKT pathway and is associated with poor prognosis in melanoma." (2024). Articles, Abstracts, and Reports. 9028.
https://digitalcommons.providence.org/publications/9028
10.18632/oncotarget.28590